Pharmaceuticals Industry in India - Analysis of Growth, Trends and Forecast (2017 - 2022)

If India grow in future at current levels, average household incomes will double over the next few years, making India, 2nd largest consumer by 2020, up from the current 3rd position. India is 13th largest in terms of value. India is the largest provider of generic drugs globally, which accounts for 20% of global pharmaceutical exports in terms of volume. India has a large pool of scientists and engineers who have the potential to direct the industry ahead to even higher levels.

Global organizations view India as one of the prime market, where future growth is promising. Growth in Indian consumer market would be largely driven by a favorable population composition and increasing disposable income and increasing awareness. Indian Pharmaceuticals market is expected to become US$ 28 billion by 2020. India ranks 2nd in number of pharmaceutical production facilities after US.

The pharmaceuticals sector attracted foreign direct investment (FDI) inflows of US$ 13.34 billion between April 2000 and June 2015. Indian Government unveiled 'Pharma Vision 2020' program aimed to make India a global leader in drug manufacturing. Indian and global companies have expressed investment intentions worth US$ 150.84 million in the pharmaceutical sector in Gujarat State. The memorandums of understanding (MoUs) are signed during the Vibrant Gujarat Summit.

India is well recognized Pharmaceuticals manufacturing hub in the world because of its low cost production. Cheap labor, easy availability and low cost of raw materials and weak currency are the factors that are driving pharmaceutical Industry. Growing working population and expanding middle class are the main drivers for the growth of Pharmaceuticals industry in India.

Make in India initiative have boosted the Pharmaceuticals manufacturing industry in India and as a result we will witness a marvelous growth in the industry over a period of time. Indian Pharmaceuticals Industry is expected to grow with a CAGR of xx.xx% till 2020.

What the report offers

The study elucidates the situation of India and predicts the growth of its Pharmaceuticals industry. Report talks about growth, market trends, progress, challenges, opportunities, government regulations, technologies in use, growth forecast, major companies, upcoming companies and projects etc. in the Pharmaceuticals Sector of India. In addition to it, the report also talks about economic conditions of and future forecast of its current economic scenario and effect of its current policy changes in to its economy, reasons and implications on the growth of this sector. Lastly, the report is segmented by various types of Minerals and Metals available in the country.

1. Research Methodology

2. Key Findings of The Study

3. Executive Summary

4. Market Overview

4.1 Introduction

4.2 Industry Value Chain Analysis

4.3 Industry Attractiveness ? Porter?s 5 Force Analysis

4.4 Industry Policies

5. Market Dynamics

5.1 Introduction

5.2 Drivers

5.2.1 Rise in population growth rates

5.2.2 Huge Demand for Specialized Medicine and Equipment

5.2.3 Relatively well developed Helathcare Sector

5.3 Restraints

5.3.1 Sentiment against foreign interference

5.3.2 Falling expenditures on healthcare sector

5.4 Trends

5.4.1 India ranked 46th most efficient healthcare system in the world

6. India Healthcare Market

6.1 Overview

6.2 Segmentation By Type

6.2.1 Generic Drugs

6.2.2 Specialized Drugs

6.2.3 Others

7. Investment Analysis

7.1 Recent Mergers And Acquisitions

7.2 Investment Outlook

8. Future of India Healthcare Market

9. Competitive Intelligence ? Company Profiles

9.1 Cipla

9.2 Dr. Reddy's Lab

9.3 Lupin

9.4 Sun Pharma

9.5 Cadila

9.6 GlaxoSmithKline

9.7 Biocon

9.8 Pfizer

9.9 Novartis India

9.10 Merck

9.11 Sun Pharma

Content are not available

Choose License Type